(R)-1-(2-Chloro-6-fluorophenyl)ethanamine is primarily used in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its stereochemistry makes it valuable in the development of enantiomerically pure drugs, particularly those targeting the central nervous system. The compound is often employed in the production of antidepressants, antipsychotics, and other neuroactive agents due to its ability to interact with specific receptors in the brain. Additionally, it serves as a key intermediate in the synthesis of compounds with potential therapeutic applications in treating neurological disorders. Its unique structure allows for the creation of molecules with enhanced efficacy and reduced side effects, making it a crucial component in modern drug discovery and development.